NewLeaf Symbiotics, global leader and pioneer of pink-pigmented facultative methylotrophs (PPFMs), announces the fully funded close of its series D financing round, totaling $45 million. This round was led by new investor Gullspang Re:food and followed by Otter Capital Partners LP, S2G Ventures, Leaps by Bayer and others.

NewLeaf Symbiotics is an agricultural biotech leader that is focused on the discovery, development, production and commercialization of products containing a genus of beneficial microbes that are ubiquitous and naturally symbiotic with plants. The pioneer and global leader of pink-pigmented facultative methylotrophs (PPFMs), NewLeaf's technology outcomes include increased yield potential and sustainability indicators. Headquartered in the Ag Innovation capital of St. Louis, NewLeaf has filed more than 200 patents and patent applications and introduced its first biostimulant products in the United States for corn and soy.